You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.
The New York startup is curating available data for all Emergency Use Authorized molecular diagnostic tests for the benefit of the public.
Funding from RADx and NIAID will enable the scale-up of multiplexed viral detection microarrays to 4 million tests per month.
The firm is using ddPCR to support testing 3,000 samples per day with a turnaround time of approximately 24 hours
Grassroots efforts are leading the way in a number of commercial and non-commercial screening tests in development.
CEO Doug Bryant noted, in particular, what he expects will be a hunger for rapid protein-based antigen tests for the coronavirus that the market currently can't fill.
A SNP in the pan-SARS E gene has not affected patient results, but has raised concerns about the overall unavailability of commercial primer and probe information.
The agency has provided new guidance for tests that can be used outside of a lab setting, as well as updated its guidance on a number of other topics.
Cities and start-ups are pushing to incorporate SARS-CoV-2 wastewater monitoring into pandemic responses even as basic science researchers scramble to hammer out methods.
The firm launched a CE-IVD marked test for extremely drug-resistant TB and expects to incorporate the multiplexing technology in other assays.
A handful of researchers and companies are hoping to finally bring the paper-based molecular diagnostic space to fruition.
According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.
A number of United Nations agencies push for scientific findings to be made accessible through open science.
Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.
In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.